Evidence map›Paper›PMID 24520079›Full record

ArticleReproductive sciences (Thousand Oaks, Calif.)2014

Biocompatibility of a sonicated silk gel for cervical injection during pregnancy: in vivo and in vitro study.

Agatha S Critchfield, Reid Mccabe, Nikolai Klebanov, Lauren Richey, Simona Socrate, Errol R Norwitz, David L Kaplan, Michael House

Abstract read
In one paragraph

Article in Reproductive sciences (Thousand Oaks, Calif.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Tissue Engineering for Cervical Function in Pregnancy.Current opinion in biomedical engineering · 2022
    Article
  3. Next generation strategies for preventing preterm birth.Advanced drug delivery reviews · 2021
    Review
  4. Article
  5. Article
  6. Ex vivo pregnant-like tissue model to assess injectable hydrogel for preterm birth prevention.Journal of biomedical materials research. Part B, Applied biomaterials · 2020
    Article
  7. Review
  8. Review
  9. Article
  10. [Application of silk-based tissue engineering scaffold for tendon / ligament regeneration].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2016
    Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Agatha S CritchfieldDepartment of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Tufts Medical Center, Boston, MA, USA.
Reid MccabeDepartment of Biomedical Engineering, Tufts University, Medford, MA, USA.
Nikolai KlebanovDepartment of Biomedical Engineering, Tufts University, Medford, MA, USA.
Lauren RicheyDivision of Laboratory Animal Medicine, Tufts University, Boston, MA, USA.
Simona SocrateHarvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA.
Errol R NorwitzDepartment of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Tufts Medical Center, Boston, MA, USA.
David L KaplanDepartment of Biomedical Engineering, Tufts University, Medford, MA, USA.
Michael HouseDepartment of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Tufts Medical Center, Boston, MA, USA mhouse@tuftsmedicalcenter.org.

Funding

REPRODUCTIVE SCIENTIST TRAINING PROGRAMK12HD000849 · NICHD · WASHINGTON UNIVERSITY · PI Danny J Schust · 1988 to 2026
$33.2M
Translational Bioreactors - Engineering Complex TissuesP41EB002520 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2004 to 2018
$16.7M
NIBIB NIH HHS P41 EB002520NICHD NIH HHS 2K12HD000849-26NICHD NIH HHS K12 HD000849
6 · The paper itself

Abstract

objectiveTo evaluate the biocompatibility of silk gel for cervical injection. STUDY

designSilk gel was injected into the cervix of pregnant rats on day 13 (n = 11) and harvested at day 17. Histology of silk gel was compared with suture controls. Also, human cervical fibroblasts were cultured on silk gel and tissue culture plastic (TCP) in vitro. Cell viability, proliferation, metabolic activity, gene expression (COL1A1, COL3A1, and COX2), and release of proinflammatory mediators (interleukin [IL] 6 and IL-8) were evaluated.

resultsIn vivo, a mild foreign body response was seen surrounding the silk gel and suture controls. In vitro, cervical fibroblasts were viable, metabolically active, and proliferating at 72 hours. Release of IL-6 and IL-8 was similar on silk gel and TCP. Collagen and COX2 gene expression was similar or slightly decreased compared with TCP.

conclusionsSilk gel was well tolerated in vivo and in vitro, which supports continuing efforts to develop silk gels as an alternative to cervical cerclage.

Indexed as

Administration, IntravaginalAnimalsBiocompatible MaterialsCells, CulturedCell SurvivalCerclage, CervicalCervix UteriFemaleHumansPregnancyRatsSilkSonicationBiocompatible MaterialsSilkcerclagecervixinjectable biomaterialpreterm birthsilk

Identifiers

PMID24520079
PMCPMC5933181

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.